What changes to federal IDR is Congress considering?
Congress is considering competing responses to the No Surprises Act's federal payment-dispute process, but neither bill is enacted law. Rep. Frank Pallone's Lower Premiums, Faster Payments Act would replace federal IDR for future services with a payment standard tied to a recalculated qualifying payment amount, or QPA. The bipartisan No Surprises Act Enforcement Act, introduced in the House by Rep. Greg Murphy, would preserve IDR and add consequences when a party does not satisfy a final determination on time.
The distinction is fundamental. The Pallone proposal changes who effectively sets the out-of-network rate. The Murphy proposal leaves neutral review in place and targets compliance with the result. Congress should not treat payment methodology, process volume, and award enforcement as if they were the same policy question.
What did MedPage Today report?
MedPage Today's report describes a debate that begins with broad agreement on one point: the No Surprises Act removed patients from many unexpected out-of-network payment disputes. The disagreement is over what should happen between providers and health plans after the patient is protected.
Jack Hoadley, professor emeritus at Georgetown University's Center on Health Insurance Reforms, discussed the unexpectedly high use of arbitration and the approximately 85% provider prevailing percentage. The article also describes the history of the QPA, including early federal rules that gave it special weight and court decisions that rejected that approach.
Philadelphia attorney Josh Hill addressed a different problem: the statute requires payment following a determination within 30 days, while recent appellate decisions have limited providers' ability to sue to collect an unpaid award. That enforcement gap is not answered by statistics about total dispute volume or prevailing parties.
How do the Pallone and Murphy proposals differ?
The Lower Premiums, Faster Payments Act would end federal IDR for items and services furnished on or after January 1, 2028 and generally use a recalculated QPA as the out-of-network payment rate. It also includes a payment deadline and auditing provisions. Supporters characterize the QPA as a market benchmark; providers have long argued that a plan-calculated median can become an insurer-controlled ceiling unless its inputs, calculation, and audit results are reliable and transparent.
The No Surprises Act Enforcement Act, H.R. 4710 and S. 2420, addresses performance after a final determination. It would reinforce the 30-day payment obligation, authorize a penalty generally tied to three times the difference between the initial payment and the IDR amount plus interest, clarify federal enforcement authority, and require reporting on compliance. It does not replace neutral payment review with the QPA.
As of this publication, neither proposal is enacted law. The Pallone measure is a newer structural alternative; the Murphy measure remains pending after its 2025 introduction. Providers should track actual legislative action rather than treating a press release or introduced bill as a change to present deadlines.
Why do the dispute-volume and win-rate numbers need context?
The scale of federal IDR is far above the government's first-year estimate. The 2026 federal IDR final rule recalls an estimate of 17,333 non-air-ambulance disputes plus 4,899 air-ambulance disputes for the first year. CMS's July 2026 interim report lists 2,559,375 disputes initiated during 2025, while the final rule reports more than 5.1 million cumulative submissions as of January 31, 2026.
Those figures answer different questions. An annual total should not be confused with a cumulative count, and neither number identifies why a dispute was filed. The volume may reflect low initial payments, eligibility disagreements, changes in batching, data-entry practices, growing familiarity with the process, concentration among a small number of organizations, or some combination of factors.
The approximately 85% provider win rate also does not prove abuse or establish the cause of the outcomes. A serious evaluation must examine plan defaults, nominal offers, the reliability of the QPA, both parties' submitted offers, claim mix, eligibility, and whether the awarded amount was actually paid. A prevailing-party percentage by itself cannot supply that missing record.
What is missing from the enforcement debate?
A final IDR determination has limited value if the prevailing provider cannot collect it promptly. The statute calls the determination binding and establishes a payment deadline, yet courts have disagreed over or limited the remedies available to providers seeking payment. Regulatory complaint channels are not the same as a clear, claim-level collection remedy.
Replacing IDR with a benchmark would reduce the number of future awards, but it would not explain past nonpayment or resolve whether plans complied with existing determinations. Conversely, enforcing awards does not answer every concern about eligibility, capacity, administrative cost, or the integrity of submitted data.
Congress should therefore measure payment compliance directly: amount due, date due, amount paid, date paid, dispute status, enforcement referral, and resolution. Without that data, policymakers can count awards without knowing whether providers recovered them.
Halkovich Law's commentary
The current debate is too often framed as a binary choice between an unrestricted arbitration system and an insurer-calculated benchmark. That framing skips the central provider concern: neutral review exists because the health plan controls the initial payment and calculates the QPA used in the dispute.
If Congress gives the QPA decisive effect, it must first establish that the benchmark is complete, correctly calculated, consistently disclosed, and independently auditable. Federal audit findings and litigation over QPA methodology make that more than a technical concern. A benchmark cannot be treated as neutral merely because it has a statutory name.
At the same time, federal IDR needs operational discipline. Eligibility screening, standardized claim information, workable batching, IDR-entity capacity, transparent reporting, and consequences for defaults or nominal participation can improve the process without eliminating case-specific neutral review.
The strongest near-term reform would separate the questions Congress is trying to answer: improve process integrity, verify the payment evidence, and enforce final determinations. Changing the payment standard before resolving those factual questions risks replacing a visible dispute process with a less visible pricing decision controlled by one party.
What should a workable federal IDR reform include?
- Reliable QPA data. Require complete disclosures, independent audits, correction procedures, and public reporting that identify material calculation errors.
- Meaningful participation. Report defaults and nominal offers separately and establish consequences when a party does not engage with the process in good faith.
- Clear payment enforcement. Preserve the 30-day obligation, track compliance, and provide an effective remedy when a final determination is not paid.
- Better eligibility and batching tools. Give parties standardized information early enough to determine coverage and group comparable claims efficiently.
- Outcome data that follows the money. Connect the initial payment, submitted offers, award, fees, actual payment, and payment date without confusing awards with recoveries.
- Patient-access monitoring. Evaluate network adequacy, contracting behavior, practice stability, and appointment access alongside premiums and award amounts.
Frequently asked questions
What No Surprises Act changes is Congress considering?
Has Congress eliminated federal IDR?
Does the 85% provider win rate prove the process is being abused?
How many federal IDR disputes were initiated in 2025?
What should providers do while Congress debates reform?
Sources and scope
This article is Halkovich Law's original provider-side commentary on the MedPage Today article “Congress Mulls Ways to Fix the Surprise Billing Law.” It is not a reproduction of the source article. MedPage Today's interviews and characterizations are attributed to that publication; legislative structure and federal volume figures were checked against official committee, GovInfo, and CMS materials available on November 21, 2026.
Legislative proposals can change. The figures above distinguish annual initiations from cumulative submissions and do not establish a cause for filing growth. This page provides general information, not legal advice for a particular claim, dispute, plan, or pending bill.
Prepare for the rule in force—not the headline.
Halkovich Law can assess federal IDR eligibility, payer payment patterns, unpaid determinations, portfolio economics, and the records needed to pursue provider recovery.